Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

NCT04150562 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
NIH
Sponsor class

Stopped This study was terminated early due to manufacturer withdrawal of support (study medication) due to lack of enrollment.

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)